Colorex

Quick links to important sections

Colorex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Colorex

What is Colorex?

Colorex is a pharmaceutical formulation primarily utilized for the management and treatment of specific fungal infections. It belongs to a class of medications known as antifungals, which work by disrupting the growth and reproduction of fungal cells.

Mechanism of Action

The active components in Colorex target the integrity of the fungal cell membrane. By interfering with the synthesis of essential lipids or proteins required for the cell wall, the medication causes the cellular contents to leak, leading to the eventual neutralization of the organism. This mechanism is designed to be selective, aiming to minimize impact on human cells while effectively addressing the fungal presence.

Primary Uses

Colorex is commonly indicated for various types of fungal conditions, which may include:

  • Superficial Mycoses: Infections affecting the skin, hair, or nails.
  • Systemic Fungal Infections: Internal infections that require a broader approach to treatment.
  • Prophylactic Use: In certain clinical scenarios, it may be used to prevent the development of fungal overgrowth in individuals with compromised immune systems.

Therapeutic Goal

The primary objective of Colorex therapy is to alleviate the symptoms associated with fungal overgrowth—such as inflammation, itching, or irritation—and to clear the underlying infection. Treatment duration and efficacy often depend on the specific type of fungus involved and the location of the infection within the body.

What side effects are possible with Colorex?

Possible Side Effects and Safety Information

The safety profile of Colorex (Balsalazide) is formally defined by official regulatory documentation, which classifies potential adverse reactions by frequency and physiological system. Since Balsalazide is a prodrug, its safety profile is largely associated with the release of its active component, mesalamine (5-ASA).

Frequency-Classified Adverse Reactions

The most frequently documented reactions impact the nervous and gastrointestinal systems.

Classification Examples of Officially Listed Reactions
Very Common (ge 10%) Headache
Common (ge 1% to 10%) Abdominal pain, Diarrhea, Nausea, Vomiting, Pyrexia (fever), Arthralgia (joint pain)

Serious Adverse Reactions and Restrictions

Official labeling describes several serious adverse reactions, which, while rare, are clinically significant. These include Mesalamine-Induced Acute Intolerance Syndrome, which may present with symptoms similar to a severe exacerbation of ulcerative colitis. Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome, have also been reported.

The drug is formally contraindicated in patients with known hypersensitivity to salicylates. Furthermore, regulatory documents emphasize the need for caution in patients with pre-existing hepatic or renal impairment, and require that renal function be evaluated prior to starting therapy and periodically thereafter. The safety profile for pediatric patients is generally considered similar to that of adults.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for overdose describes specific, time-sensitive symptoms and required actions to ensure appropriate medical intervention.

Documented Overdose Manifestations

Overdose presentations documented in official sources primarily involve significant effects on the neurological and cardiovascular systems.

Physiological System Documented Overdose Presentation
Central Nervous System Seizure, loss of consciousness, hallucinations
Cardiovascular System Rapid or pounding heartbeat (Tachycardia), conduction abnormalities

Serious outcomes that are noted include life-threatening cardiac dysrhythmias and the potential for status epilepticus (recurrent seizures).

Mandated Emergency Actions

The most critical instruction in an overdose situation is to seek immediate professional medical assistance. Regulatory documents strictly define when this action must be taken:

  • Call the Poison Control Helpline immediately upon suspected overdose.
  • Call Emergency Services (e.g., 911) if the individual has collapsed, experienced a seizure, is having trouble breathing, or cannot be awakened (loss of consciousness).

No specific chemical antidote is typically listed in consumer-facing regulatory summaries; management in a healthcare setting is largely supportive, focusing on observation and symptom control. Observation for up to 24 hours may be required to monitor for delayed-onset seizures following ingestion of certain formulations.

Therapeutic Uses of Colorex

What Colorex Treats: Main Uses and Benefits

The medication Colorex is relevant for easing symptoms in conditions involving inflammatory or irritative processes, such as ulcerative colitis, which is a condition characterized by periods of heightened symptoms. It is applied across domains where additional symptomatic support is needed. It helps address symptom clusters that may become intense or disruptive, such as frequent, bloody diarrhea, abdominal pain/cramping, and rectal bleeding.

It is commonly used in situations involving certain distressing symptoms during acute episodes and may be part of symptomatic management intended to address future recurrence. The treatment may be part of symptomatic management that supports general well-being. In short, the medication is relevant for easing the overall symptom load during active phases and is considered relevant for long-term management.


Quick Facts: Therapeutic Support

  • Relief for Gastrointestinal Distress: The treatment may assist with maintaining functional stability by addressing symptoms that interfere with daily functioning, supporting patients during episodes of heightened discomfort.
  • Stability Support: This therapeutic focus may assist with maintaining functional stability over time. It helps reduce the risk of symptom recurrence, contributing to a more manageable experience.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Colorex (Balsalazide) is primarily indicated for individuals with inflammatory bowel diseases (IBD), specifically in the treatment of ulcerative colitis and sometimes Crohn's ileocolitis. Its use is focused on reducing inflammation in the colon and rectum to help manage symptoms and maintain remission.


Contraindications and Precautions

Colorex is not suitable for everyone. It is contraindicated in patients with a known hypersensitivity or allergy to salicylates (like aspirin) or to any component of the medication. It is also generally not recommended for patients with moderate to severe kidney disease or those with severe liver impairment.

Caution and medical consultation are essential for several patient groups, as the medication may require dose adjustment or close monitoring:

  • Existing Conditions: Patients with pre-existing kidney or liver problems, a history of pyloric stenosis or other gastrointestinal obstructions, or a history of asthma should use Colorex only after careful medical evaluation.
  • Pregnancy and Breastfeeding: While some data suggest it may be used with caution during pregnancy when benefits outweigh risks, its use during breastfeeding is generally discouraged due to the possibility of the active component passing into breast milk and causing infant diarrhea.
  • Children: Safety and efficacy are not established for all forms in children, and specific age restrictions apply depending on the formulation. Patients with known blood disorders should also proceed with caution.

What should I know about interactions with other medicines?

Officially Documented Drug-Drug Interactions

Regulatory documentation specifies several interactions concerning additive risk. Co-administration with nephrotoxic agents, including Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), may result in an increased risk of renal adverse reactions. Similarly, concurrent use with Azathioprine or 6-Mercaptopurine (myelotoxic agents) may increase the potential for blood disorders. The label notes that this risk of blood dyscrasias is particularly heightened in geriatric patients.

From a pharmacokinetic standpoint, the drug's acetylated metabolites may compete with the active renal tubular secretion of co-prescribed medicines, which could lead to raised plasma concentrations of those drugs. Conversely, in vitro data suggests Colorex and its metabolites do not inhibit major Cytochrome P450 enzymes such as CYP1A2 or CYP3A4/5. The use of orally administered antibiotics could, theoretically, interfere with the specific bacterial process required for the prodrug’s activation in the colon.

Other Interaction Constraints

Official regulatory information also defines interactions related to administration and laboratory testing. Systemically available amounts of Balsalazide may be increased when administered in the fasting state compared to the fed state. Furthermore, the drug is documented to interfere with a specific laboratory procedure, potentially causing spuriously elevated test results when measuring Urinary Normetanephrine via liquid chromatography with electrochemical detection.

Mechanism of Action

Prodrug Activation for Localized Delivery

The action of Colorex is governed by the targeted delivery and multi-pathway anti-inflammatory mechanism of its active component, 5-aminosalicylic acid (5-ASA). The medicine is initially an inactive prodrug (Balsalazide) chemically linked by an azo bond, which prevents absorption until it reaches the lower bowel. The mechanism is initiated when colonic bacteria release specific azoreductase enzymes, which cleave the azo bond and release the active 5-ASA directly onto the mucosal surface. This process results in a high concentration of the active moiety at the site of action, with minimal systemic absorption.


Dual Inhibition and Gene Modulation

Once released, 5-ASA acts by inhibiting two distinct enzyme families: Cyclooxygenase (COX-1 and COX-2) and 5-Lipoxygenase (5-LOX). These enzymes drive the Arachidonic Acid Cascade; by blocking their production, the drug reduces the concentration of lipid mediators (prostaglandins and leukotrienes) that promote localized tissue edema and vascular changes. Concurrently, 5-ASA engages the nuclear transcription factor Peroxisome Proliferator-Activated Receptor gamma (PPAR-γ) and suppresses the activity of the NF-κB transcription factor. This action reduces the cell's capacity to synthesize and release pro-inflammatory proteins, or cytokines, thereby modulating the signaling patterns characteristic of persistent inflammatory activity.

Dosage and Administration Information

How to Use Colorex: Official Administration Guidelines

Colorex is an orally administered medicine that requires specific dosing and preparation, strictly following the regimen prescribed by a healthcare provider. The official instructions for use mandate a precise, structured approach to ensure proper administration.

Administration and Timing

Administration Scope Official Requirement
Route of Administration Oral (as solution, capsules, or tablets)
Dosing Schedule Varies (e.g., Two-Day Split-Dosing or One-Day Morning Dosing), typically requiring two separately timed administrations for the complete regimen.
Timing in Relation to Meals Tablets or granules must be taken with food. Certain oral solutions may be taken on an empty stomach or with food if necessary in stable patients.
Fluid/Dietary Constraints Consume additional clear liquids throughout the treatment. Only clear liquids (no solid food) may be consumed from the start of specific treatments until after the procedure.

Preparation and Procedural Rules

  • Preparation Requirements: For powdered forms, the contents must be reconstituted with water in the provided mixing container and mixed thoroughly until completely dissolved. Do not reconstitute with other liquids or add starch-based thickeners.
  • Age-Group Administration: Specific dosage recommendations exist for both adults and pediatric patients (typically geq 3 months of age), with some pediatric dosing based on body surface area (BSA).
  • Missed-Dose Rules: If severe symptoms (such as bloating, abdominal distention, or pain) occur following the first dose of a two-dose regimen, the second dose must be delayed until these symptoms resolve.
  • Procedural Condition: Any pre-existing fluid and electrolyte abnormalities must be corrected before starting this treatment.

These official administration guidelines dictate the exact time, method, and consumption environment for the medicine to ensure standardized use.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Colorex (Balsalazide)

The research landscape for Colorex centers on randomized controlled trials (RCTs) and long-term observational studies. This evidence describes the observations from studies regarding the agent's use in conditions characterized by cycles of stability and flare-ups, focusing on how symptoms were measured in adult and pediatric populations. The findings describe group patterns and contribute to the broader evidence landscape, and research cannot predict individual patient responses.

Evidence for Use in Mildly to Moderately Active Ulcerative Colitis

Research exploring this condition focused mainly on short-term, defined time intervals, typically lasting 8 to 12 weeks. The designs used were primarily RCTs, which often compared the agent against a placebo or another active comparator (such as other 5-ASA agents). Studies monitored outcomes related to physical discomfort and outcomes linked to inflammatory states. The primary outcomes measured in these trials included assessments for Clinical Remission and the degree of Mucosal Healing (improvement in the inflammation measured by visual assessment).

Evidence for Use in Maintaining Remission in Ulcerative Colitis

For patients whose condition is currently inactive, research explored how to sustain this stable state. These studies used longer-term Randomized Controlled Trials and subsequent observational settings, which were designed to evaluate the duration of the quiescent period over months. Researchers examined outcomes related to systemic or functional imbalance, such as the proportion of patients remaining relapse-free and the time until the return of active symptoms.

What Remains Uncertain in the Research Landscape

Research highlights what is known—and what is still uncertain—about this agent. Long-term effects are not fully established, and there is limited information for outcomes beyond the measured clinical trial periods. Furthermore, regulatory reviews of some initial studies noted inconsistent patterns when comparing outcomes between male and female participants, which highlights that caution is needed when generalizing individual trial results across all subgroups.

Frequently Asked Questions (FAQ)

Common questions about Colorex (FAQ)


Q: Does Colorex cause kidney issues or kidney stones?

Official safety information indicates that this drug may increase the risk of developing kidney stones (renal calculi) in some patients. Fluid intake is a recognized medical consideration during treatment. This practice is often noted as a way to manage the risk of developing renal calculi.


Q: What are the risks of taking Colorex during pregnancy?

According to official documents, Colorex is generally classified as Pregnancy Category B. This classification means that animal reproduction studies have not demonstrated a risk to the fetus, but there are not enough well-controlled studies conducted in pregnant women. The decision to use the medication during pregnancy requires a medical determination that the potential benefit to the patient justifies the potential risk.


Q: What happens if I forget to take a dose of Colorex?

Official guidance covers how to handle a missed dose, typically advising to take it when remembered unless it is nearly time for the next dose, in which case the missed dose is skipped. The guidance specifies that patients should not take a double dose to make up for the missed one.


Q: What is the difference between the capsule form and the tablet form of Colorex?

Official product information indicates that the different oral forms of Colorex (capsules versus tablets) may be intended for different patient populations or specific uses. For instance, some tablet forms are not recommended for use in children or female patients. These distinctions are based on how the drug was studied and approved for use in specific groups.


Q: What are the signs of a severe allergic reaction to Colorex (like DRESS syndrome)?

Signs of a severe or serious reaction may include the development of generalized hives, swelling of the face, lips, tongue, or throat, or difficulty breathing. The development of symptoms such as fever, severe stomach cramps, or bloody diarrhea may indicate a rare intolerance syndrome. If any severe signs are observed, patients should immediately contact a healthcare professional.


Q: Why do official sources say Colorex should be used with caution in patients with asthma?

Official regulatory documents contain a caution regarding the use of Colorex in individuals with pre-existing asthma. This caution is recommended because there is an increased risk of the patient's respiratory condition worsening while taking the medication.


Q: Is it common to experience joint pain or muscle aches while on Colorex?

Joint pain (arthralgia) is listed in official documents as a common side effect of Colorex. Other musculoskeletal effects, such as muscle cramps or muscle twitching, have also been reported in patient safety information.


Q: Is it safe to drink alcohol while I am being treated with Colorex?

Official patient guidance states that consultation with a healthcare professional regarding the use of alcohol is required.


Q: Is there a maximum time someone can stay on Colorex treatment?

Clinical trials for the treatment of active ulcerative colitis established the safety and effectiveness of this medication for up to 12 weeks in adults and 8 weeks in children (ages 5-17 years). Use beyond these defined durations has not been established in clinical trial settings.


Q: Is there a generic version of Colorex available?

Yes, regulatory data indicates that a generic version of the brand-name product (Colazal) has been approved by the FDA. Generic versions are generally available as an alternative to the branded medication.


Q: Can Colorex be crushed or split if I have trouble swallowing pills?

The capsule form of this medication is required by the label to be swallowed whole and is not meant to be cut, broken, crushed, or chewed. However, the official label includes a specific administration instruction that permits the capsules to be opened and the contents sprinkled on a soft food like applesauce, to be chewed and swallowed immediately.


Q: Can Colorex be used to treat conditions other than what is listed in the official uses?

Colorex is officially indicated for the treatment of mildly to moderately active ulcerative colitis. Regulatory documents limit the established uses to those conditions for which the drug has demonstrated evidence of safety and effectiveness.


Q: Does Colorex interact with blood thinner medications?

Yes, official drug interaction data indicates that Colorex may interact with certain blood thinners, such as warfarin, and has the potential to alter their effects. Co-administration may require increased monitoring by a healthcare professional.


Q: Can Colorex cause an increased sensitivity to the sun?

The official patient safety information states that Colorex may cause increased sensitivity to the sun, a condition known as photosensitivity. This effect can make the skin easier to burn when exposed to sunlight.


Q: Can Colorex affect fertility or sexual health?

Regulatory reviews of the drug included studies conducted in animals, which found that the medication had no effect on fertility or reproductive performance. Currently, there is no specific data available from studies on human fertility.


Q: Does Colorex have any known interactions with vaccines, such as the varicella vaccine?

Yes, a serious drug interaction has been reported with certain live vaccines, which include the varicella (chickenpox) virus vaccine. Regulatory patient safety literature recommends informing a healthcare professional about all medications taken prior to receiving a vaccine.


Q: Does Colorex make you feel tired or cause drowsiness?

Fatigue (feeling tired) is listed in the official documents as a common adverse effect. However, regulatory patient information specifically notes that the drug does not typically cause sleepiness or drowsiness.


Q: Why does my urine sometimes look reddish-brown after taking Colorex?

It is documented as a normal finding to notice that your urine may look reddish-brown when it comes into contact with surfaces or water that has been treated with bleach. This is a known chemical interaction noted in patient documentation.


Q: What is the risk of stopping Colorex suddenly?

Official guidelines state that discontinuation or alteration of the treatment regimen must occur under the direct supervision of a healthcare professional. This is a requirement specified in the regulatory patient information.


Q: Does Colorex have an effect on mood or cause depression?

Yes, official patient safety information lists depression as a reported side effect of the medication. Regulatory patient safety literature notes that changes in mood should be communicated to a healthcare provider.


Q: Is Colorex known to cause any hair loss?

Hair loss or thinning of the hair has been reported as an adverse reaction in patient safety information. However, the exact incidence or frequency of this side effect is not known.


Q: Does Colorex have interactions with herbal remedies or vitamins?

Official guidance states that consultation with a healthcare professional regarding the use of any herbal remedies, vitamins, or supplements is required before starting or continuing this medication.


Q: What should a patient do if they develop a persistent cough while taking Colorex?

Regulatory patient safety practice is to contact a healthcare professional if any persistent or unexpected symptoms, such as a cough, are experienced during treatment. This information is for education and is not intended to manage symptoms.


Q: Does Colorex contain sulfa ingredients that people might be allergic to?

Colorex is an aminosalicylate, a class of drug chemically related to salicylates (like aspirin). While it does not contain the sulfa (sulfonamide) group, it is formally contraindicated (should not be used) in patients with a known hypersensitivity or allergy to salicylates.


Q: Can Colorex make my skin break out in a rash or hives?

Official patient safety information lists skin rash and itching as reported side effects. More severe skin reactions, such as generalized hives (urticaria), have also been observed, which may be a sign of a serious reaction.

How should Colorex be stored and disposed of?

Storage and Disposal of Colorex (Balsalazide)

Official labeling defines specific storage and disposal requirements for Colorex (Balsalazide).


Storage Conditions

The medication must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F), and must be protected from freezing, excessive heat, moisture, and direct light. The container must be kept tightly closed in its original packaging. For child safety, the medicine must be stored out of the sight and reach of children.

Stability and Handling

If a dose is prepared by mixing the capsule contents with food, the mixture must be consumed immediately and must not be stored for future use.

Disposal Instructions

Unused or expired Colorex must not be thrown away in household waste or via wastewater. Patients should consult a pharmacist or healthcare provider for instructions on proper disposal, such as using a medicine take-back program, to comply with local and national regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Colorex found in:

A-Z Index: